Profil
Mark Auerbach served as Chairman, President, Chief Executive Officer & CFO at Sterling Infrastructure, Inc. from 1995 to 1997.
He was also Executive Chairman at Endo Generics Holdings, Inc. and Non-Executive Chairman at Par Pharmaceutical, Inc. in 2006.
From 2006 to 2010, he served as Chairman at Woodbrook Group Holdings, Inc. He was a Director at RxElite, Inc., Ventrus Biosciences, Inc., RxElite Holdings, Inc., and Collexis Holdings, Inc. He also served as Lead Independent Director at Optimer Pharmaceuticals LLC from 2005 to 2013.
Since 2010, he has been an Independent Director at Assembly Biosciences, Inc. and is currently an Independent Director at Pardes Biosciences, Inc. He was previously the Chief Financial Officer & Senior Vice President at Central Lewmar LP from 1993 to 2005.
He also worked as a Partner at Masco Associates, Inc. Mr. Auerbach received his undergraduate degree from Rider University.
Anciens postes connus de Mark Auerbach
| Sociétés | Poste | Fin |
|---|---|---|
| PARDES BIOSCIENCES, INC. | Président | 01/03/2022 |
| ASSEMBLY BIOSCIENCES, INC. | Directeur/Membre du Conseil | 11/06/2020 |
| RCS CAPITAL CORP | Président | 01/06/2016 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Directeur/Membre du Conseil | 24/10/2013 |
| WOODBROOK GROUP HOLDINGS INC. | Président | 31/03/2010 |
Formation de Mark Auerbach
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Sterling Infrastructure, Inc.
Sterling Infrastructure, Inc. Engineering & ConstructionIndustrial Services Provides transportation, e-infrastructure and building services | Industrial Services |
Endo Generics Holdings, Inc.
Endo Generics Holdings, Inc. Pharmaceuticals: GenericHealth Technology Operates as a holding company with interests in developing, licensing, manufacturing, marketing and distributing generic and branded drugs in the United States | Health Technology |
RxElite, Inc.
RxElite, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets generic prescription drug products | Health Technology |
Ventrus Biosciences, Inc.
Ventrus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets phamaceutical products | Health Technology |
Rider University
Rider University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Health Technology |
Par Pharmaceutical, Inc.
Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets generic drugs and pharmaceuticals products | Health Technology |
Central Lewmar LP
Central Lewmar LP Wholesale DistributorsDistribution Services Distributes paper products and packaging materials and equipment | Distribution Services |
Woodbrook Group Holdings, Inc.
Woodbrook Group Holdings, Inc. Investment ManagersFinance Provides financial advisory services | Finance |
RxElite Holdings, Inc.
RxElite Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures generic prescription drug products | Health Technology |
Collexis Holdings, Inc.
Collexis Holdings, Inc. Information Technology ServicesTechnology Services Engages in the development of software solutions | Technology Services |
Masco Associates, Inc. | |
Aretec Group, Inc.
Aretec Group, Inc. Other Consumer ServicesConsumer Services Operates as a holding company whose subsidiaries provides tax, wealth and investment advisory services | Consumer Services |
Assembly Biosciences, Inc.
Assembly Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of products for infectious diseases | Health Technology |
Pardes Biosciences, Inc.
Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops oral antiviral treatment for COVID-19 | Health Technology |
















